AMERICAN FOUNDATION FOR BIOLOGICAL RESEARCH

American Foundation for Biological Research specializes in the development, maintenance, and production of biological reagents and preclinical models for infectious disease research, with a focused expertise in schistosomiasis parasite biology. The contractor delivers critical parasitological resources—including viable cercariae and eggs—as well as validated assays and diagnostic tools essential for vaccine development, drug screening, and immunological studies. Their technical capabilities span parasitology, in vitro parasite culture, molecular assay design, and the generation of reproducible preclinical infection models, all tailored to support high-containment biomedical research. A key differentiator lies in their sustained production of biologically authentic Schistosoma spp. life stages under controlled conditions, a niche requiring specialized biosafety infrastructure and deep expertise in helminth biology. The organization maintains a consistent, long-term relationship with the Department of Health and Human Services, delivering mission-critical biological materials and research support services for infectious disease programs under HHS agencies such as NIAID and CDC. Their work directly enables federal research into neglected tropical diseases, with contracts focused on sustaining biological supply chains for under-resourced pathogens. Their primary industry focus is in professional scientific services (NAICS 541990) and biotechnology R&D (NAICS 541711 and 541714), positioning them as a specialized provider of biological research infrastructure rather than a broad-spectrum contractor. They serve the federal biomedical research ecosystem by supplying rare, non-commercializable biological assets that are foundational to preclinical studies. As a non-certified entity based in Rockville, Maryland, the organization operates as a small, technically focused firm with deep domain specialization in parasitology and infectious disease research support. Their geographic proximity to federal research hubs enhances their ability to collaborate directly with NIH-funded investigators and public health laboratories.